Takeda to strengthen health system for rare diseases in India
These initiatives aim to improve access to healthcare for rare disease patients
These initiatives aim to improve access to healthcare for rare disease patients
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Subscribe To Our Newsletter & Stay Updated